Ms. Mozaffari et al., CONTRIBUTION OF THE SYMPATHETIC NERVOUS-SYSTEM TO HYPERTENSIVE RESPONSE TO INSULIN EXCESS IN SPONTANEOUSLY HYPERTENSIVE RATS, Journal of cardiovascular pharmacology, 27(4), 1996, pp. 539-544
Our previous studies demonstrate that chronic insulin administration e
xacerbates hypertension in spontaneously hypertensive rats (SHR). In t
he present study, we tested the hypothesis that the presser effect of
insulin in SHR is medicated by sympathetic nervous system overactivity
. Male SHR (7 weeks old) were given daily subcutaneous injection of in
sulin or vehicle for 3 days, after which each rat received an intraven
ous infusion of the peripheral ganglionic blocker hexamethonium. Two d
ays later, in a second experiment, the infusion protocol was repeated
with the alpha(2)-adrenoceptor agonist clonidine, which more selective
ly inhibits sympathetic (as compared with parasympathetic) nervous sys
tem activity. Insulin treatment for 3 days caused a significant increa
se in mean arterial pressure (MAP; 164 +/- 2 mm Hg vs. saline control
148 +/- 3 mm Hg), but ganglionic blockade with hexamethonium eliminate
d the difference in blood pressure (BP) between the insulin-treated an
d control SHR. Infusion of clonidine significantly reduced MAP in the
insulin-treated group to the level of the untreated control SHR, but t
he infusion did not reduce MAP in the latter group. In a second group
of rats, acute administration of prazosin also eliminated the differen
ce in MAP between insulin-treated and control SHR. We conclude that in
SHR the sympathetic nervous system contributes importantly to the pre
sser effect of insulin administration and that this effect may be medi
ated by the central nervous system.